Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 4.39494 | 70 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 3.92404 | 65 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 3.9666 | 66 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 3.91152 | 65 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 3.90283 | 65 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 4.05127 | 66 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 3.92469 | 64 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 3.94189 | 65 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 3.89477 | 65 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 3.97447 | 66 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 3.75611 | 63 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 4.1528 | 68 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 4.69295 | 73 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 3.8825 | 65 |